An Official ATS Statement: Grading the Quality of Evidence and Strength of Recommendations in ATS Guidelines and Recommendations-Reference-Cited by-同舟云学术

An Official ATS Statement: Grading the Quality of Evidence and Strength of Recommendations in ATS Guidelines and Recommendations

Published:2006-09 Issue:5 Volume:174 Page:605-614
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Schünemann Holger J.,Jaeschke Roman,Cook Deborah J.,Bria William F.,El-Solh Ali A.,Ernst Armin,Fahy Bonnie F.,Gould Michael K.,Horan Kathleen L.,Krishnan Jerry A.,Manthous Constantine A.,Maurer Janet R.,McNicholas Walter T.,Oxman Andrew D.,Rubenfeld Gordon,Turino Gerard M.,Guyatt Gordon

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference30 articles.

1. Haynes RB, Devereaux PJ, Guyatt GH. Clinical expertise in the era of evidence-based medicine and patient choice.ACP J Club2002;136:A11.

2. Grading quality of evidence and strength of recommendations

3. A New ATS Committee: Competing in the Marketplace of Ideas

4. A New ATS Committee

5. A New ATS Committee

Cited by 490 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjunctive aids for the detection of oral squamous cell carcinoma and oral potentially malignant disorders: A systematic review of systematic reviews;Japanese Dental Science Review;2024-12

2. Systematic analysis of levels of evidence supporting Chinese clinical practice guidelines for gastrointestinal disease;Med;2024-09

3. Deep brain stimulation for Tourette's syndrome;Cochrane Database of Systematic Reviews;2024-08-13

4. Guideline for treating relapsed or refractory myeloid leukemia in children with Down syndrome;Pediatric Blood & Cancer;2024-07-04

5. The IPTA Nashville consensus conference on post‐transplant lymphoproliferative disorders after solid organ transplantation in children: IV‐consensus guidelines for the management of post‐transplant lymphoproliferative disorders in children and adolescents;Pediatric Transplantation;2024-05-29